The synthesis of the substituted 4-alkyl/arylsulfonyl-5-amino-3-alkylthiopyrazoles as promising pharmaceutical agents with the antifungal action
DOI:
https://doi.org/10.24959/nphj.17.2158Keywords:
pyrazole, combinatorial library, synthesis, pharmaceutical agentsAbstract
One of the promising directions for development of antifungal agents is the synthesis of new chemical compounds that can be used as active pharmaceutical ingredients to produce highly effective drugs for the treatment of fungal infestations.
Aim. To create the combinatorial library of 4-alkyl/arylsulfonyl-5-amino-3-alkylthiopyrazoles derivatives for the total antimicrobial screening to search for new substances with the antifungal activity, and study their spectral properties.
Materials and methods. The methods of organic synthesis, instrumental methods of organic compound analysis were used.
Results and discussion. The design of the library of small molecules based on the core structure of 5-aminopirazole has been developed. The useful and effective synthetic scheme for preparing N1-subsituted 4-alkyl/arylsulfonyl-5-amino-3-alkylthiopyrazoles and their acylation products has been proposed and approved. This approach consists of cyclization of substituted alkyl/arylsulfoacetonitriles under the action of hydrazine hydrate with further alkylation and acylation of 5-aminopyrazoles obtained. The total yield of the target products is 50-85 %. The structure of all compounds synthesized has been confirmed using elemental analysis, 1H NMR- and chromato-mass spectrometric methods.
Conclusions. The design and the synthetic scheme for obtaining 4-alkyl/arylsulfonyl-5-amino-3-alkiltiopirazoles and products of their chemical modification have been proposed. The compounds synthesized are of certain interest as potential pharmaceutical agents and can be used to develop new antifungal agents.
References
Gilchrist, M., Wade, P., Ashiru–Oredope, D., Howard, P., Sneddon, J., Whitney, L., Wickens, H. (2015). Antimicrobial Stewardship from Policy to Practice: Experiences from UKAntimicrobial Pharmacists. Infectious Diseases and Therapy, 4 (1), 51–64. doi: 10.1007/s40121–015–0080–z
Calugi, C., Trabocchi, A., Guarna, A. (2011). Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002–2010) (2011). Expert Opinion on Therapeutic Patents, 27 (6), 381–397. doi: 10.1517/13543776.2011.551116
3. Centers for Disease Control and Prevention. Global Fungal Diseases. Available at: http://www.cdc.gov/fungal/global/index.html
Cleveland, A. A., Farley, M. M., Harrison, L. H. (2012). Changes in incidence and antifungal drug resistance in candidemia: results from population–based laboratory surveillance in Atlantaand Baltimore, 2008–2011. Clinical Infectious Diseases, 55 (10), 1352–1361. doi: 10.1093/cid/cis697
Micallef, C., Aliyu, S. H., Santos, R., Brown, N. M., Rosembert, D., Enoch, D. A. (2015). Introduction of an antifungal stewardship programme targeting high–cost antifungals at a tertiary hospital in Cambridge, England. Journal of Antimicrobial Chemotherapy, 70 (6), 1908–1911. doi: 10.1093/jac/dkv040
Ruhnke, M. (2014). Antifungal stewardship in invasive Candida infections. Clinical Microbiology and Infection, 20 (6), 11–18. doi: 10.1111/1469–0691.12622
Dzieciuch–Rojek, M., Poojari, C., Bednar, J., Bunker, A., Kozik, B., Nowakowska, M., Vattulainen, I., Wydro, P., Kepczynski, M., Róg, T. (2017). Effects of Membrane PEGylation on Entry and Location of Antifungal Drug Itraconazole and Their Pharmacological Implications. Molecular Pharmaceutics, 14 (4), 1057–1070. doi: 10.1021/acs.molpharmaceut.6b00969
Flick, A.C., Ding, H. X., Leverett, C. A., Kyne, R. E., Liu, K., Fink, S. J., O’Donnel, C. J. (2017). Synthetic Approaches to New Drugs Approved During 2015. Journal of Medicinal Chemistry. doi: 10.1021/acs.jmedchem.7b00010
Wu, Sh., Wang, Y., Liu, N., Dong, G., Sheng, C. (2017). Tackling Fungal Resistance by Biofilm Inhibitors. Journal of Medicinal Chemistry, 60 (6), 2193–2211. doi: 10.1021/acs.jmedchem.6b01203
Rösch, A., Anliker, S., Hollender, J. (2016). How Biotransformation Influences Toxicokinetics of Azole Fungicides in the Aquatic Invertebrate Gammarus pulex. Environmental Science & Technology, 6 (13), 7175–7188. doi: 10.1021/acs.est.6b01301
Raffa, D., Maggio, B., Raimondi, M. V., Cascioferro, S., Cancemi, G., Daidone, G. (2015). Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle. European Journal of Medicinal Chemistry, 97 (5), 732–746. doi: 10.1016/j.ejmech.2014.12.023
Ansari, A., Ali, A., Asifa, M., Shamsuzzaman (2017). Review: biologically active pyrazole derivatives. New Journal of Chemistry, 41, 16–41. doi: 10.1039/C6NJ03181A
Patil, A., Jadhav, R., Raundal, H., Sharma, L., Badgujar, R., Bobade, V. (2014). Synthesis and antifungal activities of diaryl pyrazoles carboxamide derivatives. Journal of Chemical and Pharmaceutical Research, 6 (8), 218–223.
Basha, Sh. Sh., Reddy, P. R., Padmaja, A., Padmavathi, V., Mouli, K. C., Vijaya, T. (2015). Synthesis and antimicrobial activity of 3–aroyl–4–heteroaryl pyrroles and pyrazoles. Medicinal Chemistry Research, 24 (3), 954–964. doi: 10.1007/s00044–014–1169–8
Li, Y.–R., Li, Ch., Liu, J.–Ch., Guo, M., Zhang, T.–Y., Sun, L.–P., Zheng, C.–J., Piao, H.–R. (2015). Synthesis and biological evaluation of 1,3–diaryl pyrazole derivatives as potential antibacterial and anti–inflammatory agents. Bioorganic & Medicinal Chemistry Letters, 25 (22), 5052–5057. doi: 10.1016/j.bmcl.2015.10.028
Lei, P., Zhang, X., Xu, Y., Xu, G., Liu, X., Yang, X., Zhang, X., Ling, Y. (2016). Synthesis and fungicidal activity of pyrazole derivatives containing 1,2,3,4–tetrahydroquinoline. Chemistry Central Journal. doi: 10.1186/s13065–016–0186–8
Tkachenko, P. V., Tkachenko, E. V., Zhuravel, I. A., Kazmirchuk, V. V., Derbisbekova, U. B. (2017). Vestnik KazNMU, 2, 307–311.
Activity prediction for a chemical substance. Available at: http://genexplain.com/pass/
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
